Literature DB >> 23103036

Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation.

Shamir R Mehta1, Sanjit S Jolly, John Cairns, Kari Niemela, Sunil V Rao, Asim N Cheema, Philippe Gabriel Steg, Warren J Cantor, Vladimír Džavík, Andrzej Budaj, Michael Rokoss, Vicent Valentin, Peggy Gao, Salim Yusuf.   

Abstract

OBJECTIVES: The purpose of this study was to determine the consistency of the effects of radial artery access in patients with ST-segment elevation myocardial infarction (STEMI) and in those with non-ST-segment elevation acute coronary syndrome (NSTEACS).
BACKGROUND: The safety associated with radial access may translate into mortality benefit in higher-risk patients, such as those with STEMI.
METHODS: We compared efficacy and bleeding outcomes in patients randomized to radial versus femoral access in RIVAL (RadIal Vs femorAL access for coronary intervention trial) (N = 7,021) separately in those with STEMI (n = 1,958) and NSTEACS (n = 5,063). Interaction tests between access site and acute coronary syndrome type were performed.
RESULTS: Baseline characteristics were well matched between radial and femoral groups. There were significant interactions for the primary outcome of death/myocardial infarction/stroke/non-coronary artery bypass graft-related major bleeding (p = 0.025), the secondary outcome of death/myocardial infarction/stroke (p = 0.011) and mortality (p = 0.001). In STEMI patients, radial access reduced the primary outcome compared with femoral access (3.1% vs. 5.2%; hazard ratio [HR]: 0.60; p = 0.026). For NSTEACS, the rates were 3.8% and 3.5%, respectively (p = 0.49). In STEMI patients, death/myocardial infarction/stroke were also reduced with radial access (2.7% vs. 4.6%; HR 0.59; p = 0.031), as was all-cause mortality (1.3% vs. 3.2%; HR: 0.39; p = 0.006), with no difference in NSTEACS patients. Operator radial experience was greater in STEMI versus NSTEACS patients (400 vs. 326 cases/year, p < 0.0001). In primary PCI, mortality was reduced with radial access (1.4% vs. 3.1%; HR: 0.46; p = 0.041).
CONCLUSIONS: In patients with STEMI, radial artery access reduced the primary outcome and mortality. No such benefit was observed in patients with NSTEACS. The radial approach may be preferred in STEMI patients when the operator has considerable radial experience. (A Trial of Trans-radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy [RIVAL]; NCT01014273).
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23103036     DOI: 10.1016/j.jacc.2012.07.050

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  70 in total

Review 1.  Optimization of Antiplatelet Therapy in STEMI.

Authors:  Abhishek Sinha; Kush Agrawal; Rahul Sakhuja
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

2.  Radial Interventions: Present and Future Indications.

Authors:  Konstantinos V Voudris; Panagiota Georgiadou; Konstantinos Charitakis; Konstantinos Marmagkiolis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

3.  Operator radiation exposure during transradial coronary angiography : Effect of single vs. double catheters.

Authors:  A Tarighatnia; L Pourafkari; A Farajollahi; A H Mohammadalian; M Ghojazadeh; N D Nader
Journal:  Herz       Date:  2017-07-17       Impact factor: 1.443

4.  Prone transradial catheterization for combined single-session endovascular and percutaneous interventions: approach, technical success, safety, and outcomes in 15 patients.

Authors:  Rajiv N Srinivasa; Jeffrey Forris Beecham Chick; Joseph J Gemmete; Bill S Majdalany; Anthony Hage; Alex Jo; Ravi N Srinivasa
Journal:  Diagn Interv Radiol       Date:  2018-09       Impact factor: 2.630

5.  Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?

Authors:  Neil J Wimmer; David J Cohen; Jason H Wasfy; Saif S Rathore; Laura Mauri; Robert W Yeh
Journal:  Am Heart J       Date:  2014-04-04       Impact factor: 4.749

Review 6.  Radial Access for Lower Extremity Peripheral Arterial Interventions: Do We Have the Tools?

Authors:  Raghuram Posham; Lindsay B Young; Robert A Lookstein; Constantino Pena; Rahul S Patel; Aaron M Fischman
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

Review 7.  Contemporary management of ST-segment elevation myocardial infarction.

Authors:  Ajay Yadlapati; Mark Gajjar; Daniel R Schimmel; Mark J Ricciardi; James D Flaherty
Journal:  Intern Emerg Med       Date:  2016-10-06       Impact factor: 3.397

8.  Clinical outcomes of femoral closure compared to radial compression devices following percutaneous coronary intervention: the FERARI study.

Authors:  Christian Fastner; Michael Behnes; Melike Ünsal; Ibrahim El-Battrawy; Uzair Ansari; Kambis Mashayekhi; Ursula Hoffmann; Siegfried Lang; Jürgen Kuschyk; Martin Borggrefe; Ibrahim Akin
Journal:  Heart Vessels       Date:  2016-11-01       Impact factor: 2.037

9.  Radial versus femoral access site for percutaneous coronary intervention in patients suffering acute myocardial infarction : A randomized prospective multicenter trial.

Authors:  Christiana Schernthaner; Matthias Hammerer; Stefan Harb; Matthias Heigert; Kurt Hoellinger; Elisabeth Lassnig; Edwin Maurer; Jochen Schuler; Peter Siostrzonek; Hanno Ulmer; Andreas Winter; Johann Altenberger
Journal:  Wien Klin Wochenschr       Date:  2017-09-12       Impact factor: 1.704

10.  Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.

Authors:  Kristian Kragholm; Sharif A Halim; Qinghong Yang; Phillip J Schulte; Judith S Hochman; Chiara Melloni; Kenneth W Mahaffey; David J Moliterno; Robert A Harrington; Harvey D White; Paul W Armstrong; E Magnus Ohman; Frans Van de Werf; Pierluigi Tricoci; John H Alexander; Robert P Giugliano; L Kristin Newby
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.